Texas 2011 - 82nd Regular

Texas House Bill HB2066

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to delegation by a physician of certain cosmetic and dermatological medical treatments.

Impact

The implementation of HB 2066 is likely to modify existing regulations associated with the practice of medicine in Texas. By permitting delegation, the bill is designed to promote efficiency within medical practices focusing on cosmetic and dermatological treatments. This change could help alleviate practitioner shortages in these areas, enhance patient access to treatments, and potentially reduce wait times for appointments. The idea is that more qualified individuals will be available to provide these services under the supervision of licensed physicians.

Summary

House Bill 2066 addresses the delegation of certain cosmetic and dermatological medical treatments by physicians. Specifically, the bill allows physicians to delegate the administration of approved pharmaceutical injectable botulinum toxin or dermal fillers to qualified physician assistants, advanced practice nurses, or other properly trained individuals. This legislative change is intended to facilitate the delivery of cosmetic services by expanding the scope of qualified personnel permitted to administer these treatments, thereby making them more accessible to patients.

Sentiment

The sentiment surrounding HB 2066 appears to be generally supportive within the medical community, particularly among practitioners who recognize the potential benefits of expanded access to cosmetic services. The positive feedback stems from the belief that the bill will allow for greater flexibility in healthcare delivery. However, there may be some concerns regarding oversight and the adequacy of training for those who will receive the delegation to ensure patient safety.

Contention

A notable point of contention relates to the balance between expanding access to care and ensuring patient safety. Advocates argue that proper training and supervision can mitigate risks, while critics may raise concerns about the potential for misuse or inadequately supervised practices in a field that can sometimes prioritize profit over safety. The success of HB 2066 will depend on the implementation of thorough training standards and regulatory oversight to ensure that the delegation of these treatments does not compromise patient health.

Companion Bills

No companion bills found.

Previously Filed As

TX HB3567

Relating to requirements for the renewal of a physician's registration permit and the delegation by a physician of certain medical acts.

TX SB160

Relating to the furnishing by pharmacists and dispensing by physicians of certain medications.

TX HB3058

Relating to the provision of certain medical treatment to a pregnant woman by a physician or health care provider.

TX HB1240

Relating to the authority of a physician to provide and dispense and to delegate authority to provide and dispense certain drugs.

TX HB2078

Relating to the authority of a physician to provide and dispense and to delegate authority to provide and dispense certain drugs.

TX HB776

Relating to prohibited practices by physicians.

TX HB1998

Relating to the regulation of physicians, the disciplinary authority of the Texas Medical Board, and the administration of the Texas Physician Health Program; increasing a criminal penalty; imposing a surcharge.

TX HB595

Relating to the dispensing of certain drugs by physicians.

TX HB3467

Relating to emergency medical services personnel and coverage by certain health benefit plans for treatment by emergency medical services personnel.

TX HB4326

Relating to the direction of utilization review by physicians.

Similar Bills

No similar bills found.